The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 13, 2024
Filed:
Jan. 20, 2021
Applicant:
Universite DE Mons, Mons, BE;
Inventors:
Alexandra Belayew, Tilff, BE;
Frederique Coppee, Havre, BE;
Celine Vanderplanck, Asquillies, BE;
Stephen Donald Wilton, Applecross, AU;
Eugenie Ansseau, Dour, BE;
Assignee:
Universite de Mons, Mons, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C12N 15/111 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/3233 (2013.01); C12N 2310/3513 (2013.01); C12N 2310/531 (2013.01); C12N 2320/33 (2013.01);
Abstract
Antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Methods, uses and further products employing such agents are also described.
Quick Actions:
Belayew, Alexandra. (2024). Agents useful in treating facioscapulohumeral muscular dystrophy (U.S. Patent No. 11898143). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11898143
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile